13F HOLDINGS REPORT
HealthInvest Partners AB
Quarter ended Q3 2025 · Filed November 4, 2025 · Accession 0001381843-25-000009
Total Value
$27.0M
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 37,244 | $3.0M | 11.19% |
| 2 | AbbVie Inc | ABBV | 92,105 | $2.3M | 8.40% |
| 3 | Neurocrine Biosciences Inc | NBIX | 102,625 | $1.5M | 5.67% |
| 4 | Merck & Co. Inc | MRK | 160,913 | $1.4M | 5.32% |
| 5 | Thermo Fisher Scientific Corp | TMO | 27,147 | $1.4M | 5.18% |
| 6 | BeiGene Ltd | BEIGF | 30,333 | $1.1M | 4.07% |
| 7 | Bridgebio Pharma Inc | BBIO | 174,722 | $963,444 | 3.57% |
| 8 | Cencora Inc | COR | 28,608 | $949,197 | 3.52% |
| 9 | Intuitive Surgical Inc | ISRG | 19,707 | $935,682 | 3.47% |
| 10 | Gilead Sciences Inc | GILD | 78,169 | $921,159 | 3.42% |
| 11 | Boston Scientific Corp | BSX | 86,680 | $898,420 | 3.33% |
| 12 | Stryker Corporation | SYK | 22,769 | $893,584 | 3.31% |
| 13 | Alkermes PLC | ALKS | 252,875 | $805,386 | 2.99% |
| 14 | Krystal Biotech, Inc | KRYS | 42,191 | $790,707 | 2.93% |
| 15 | Vertex Pharmaceuticals Inc | VRTX | 17,766 | $738,675 | 2.74% |
| 16 | Mirum Pharmaceuticals Inc | MIRM | 93,605 | $728,516 | 2.70% |
| 17 | NewAmsterdam Pharma Co NV | NAMSW | 193,625 | $584,612 | 2.17% |
| 18 | iRhythm Technologies Inc | IRTC | 29,991 | $547,610 | 2.03% |
| 19 | Edwards Lifesciences Corp | EW | 65,659 | $542,105 | 2.01% |
| 20 | Cardinal Health Inc | CAH | 30,297 | $504,854 | 1.87% |
| 21 | UFP Technologies Inc | UFPT | 22,986 | $487,081 | 1.81% |
| 22 | Merus N.V. | N5749R100 | 47,999 | $479,766 | 1.78% |
| 23 | Soleno Therapeutics Inc | SLNO | 60,156 | $431,720 | 1.60% |
| 24 | REVOLUTION Medicines Inc | RVMDW | 85,355 | $423,178 | 1.57% |
| 25 | Amgen Inc | AMGN | 13,806 | $413,620 | 1.53% |
| 26 | Dexcom Inc | DXCM | 50,872 | $363,418 | 1.35% |
| 27 | BICARA THERAPEUTICS INC | BCAX | 203,755 | $341,560 | 1.27% |
| 28 | Disc medicine inc | IRON | 45,690 | $320,529 | 1.19% |
| 29 | Universal Health Services Inc | UNH | 13,727 | $297,933 | 1.10% |
| 30 | Harmony Bioscience Holdings | HRMY | 92,074 | $269,397 | 1.00% |
| 31 | Avidity Biosciences Inc | 05370A108 | 51,978 | $240,427 | 0.89% |
| 32 | Corbus Pharmaceuticals Holding | CRBP | 175,582 | $235,802 | 0.87% |
| 33 | Arcellx Inc | ACLX | 25,732 | $224,281 | 0.83% |
| 34 | Summit Therapeutics Inc | SMMT | 92,737 | $203,404 | 0.75% |
| 35 | Autolus Therapeutics PLC | AUTL | 1,169,634 | $202,402 | 0.75% |
| 36 | Celcuity Inc | CELC | 37,157 | $194,869 | 0.72% |
| 37 | Mereo Biopharma Group PLC | MREO | 764,901 | $167,282 | 0.62% |
| 38 | Janux Therapeutics Inc | JANX | 49,820 | $129,265 | 0.48% |